 Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore
Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore
National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores
NOCIL Ltd Q2 FY2025-26 consolidated profit declines to Rs. 12.12 crores IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores
IFB Agro Industries Ltd consolidated Q2FY26 net profit surges to Rs. 22.70 crores R R Kabel Ltd Q2 FY2026 consolidated net profit jumps to Rs. 116.25 crores
R R Kabel Ltd Q2 FY2026 consolidated net profit jumps to Rs. 116.25 crores 
              Jupiter Bioscience Ltd has announced that the Board of Directors of the Company at its meeting held on May 28, 2007, has allotted 31,77,500 Equity Share Warrants to M/s. Ranbaxy Laboratories Ltd on a preferential basis representing approximately 14.91% of the expanded issued Share Capital of the Company at a price of Rs 147/- per Equity Share Warrant.
The said Equity Share Warrants convertible into Equity shares within a period of 18 months from the date of allotment OR at the time of exercise of option by M/s. Ranbaxy Laboratories Ltd which ever is earlier. The Company has already received 20% of the total consideration up front.
The stock was trading at Rs.179.75, down by Rs.5.85 or 3.15%. The stock hit an intraday high of Rs.188.45 and low of Rs.178.65. The total traded quantity was 285667 compared to 2 week average of 326585.